Genevieve Spires

Deputy General Counsel at Melinta Therapeutics

Speaker

Genevieve Spires is Deputy General Counsel at Melinta Therapeutics, a commercial-stage pharmaceutical company specializing in providing innovative therapies to patients suffering from acute and life-threatening illnesses. She counsels a diverse group of business clients, serving as primary legal counsel to the commercial, medical affairs, and clinical teams and partnering closely with compliance to provide guidance on regulatory compliance, stakeholder interactions, product promotion, and other legal and compliance matters relating to the company’s marketed products and investigational agents. Previously, Genevieve was a shareholder in Buchanan, Ingersoll & Rooney’s FDA & Biotechnology section, where she counseled pharmaceutical and device companies on FDA regulatory compliance and fraud and abuse matters, with a focus on lawful product promotion.